Conjunctival lymphoma

BMJ Case Rep. 2019 Jul 10;12(7):e229599. doi: 10.1136/bcr-2019-229599.

Authors

Jenny Jing Li¹, Weina Chen², Navid Sadeghi^{1

3}

Affiliations

¹ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
² Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
³ Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

No abstract available

Keywords: malignant and benign haematology; oncology.

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Agents, Alkylating / therapeutic use
Antineoplastic Agents, Immunological / therapeutic use
Bendamustine Hydrochloride / therapeutic use
Conjunctival Neoplasms / diagnosis
Conjunctival Neoplasms / drug therapy
Conjunctival Neoplasms / pathology*
Humans
Lymphoma, Non-Hodgkin / diagnosis
Lymphoma, Non-Hodgkin / drug therapy
Lymphoma, Non-Hodgkin / pathology*
Rituximab / therapeutic use

Substances

Antineoplastic Agents, Alkylating
Antineoplastic Agents, Immunological
Rituximab
Bendamustine Hydrochloride